Two Sigma Advisers
IMVT icon

Two Sigma Advisers’s Immunovant IMVT Stock Holding History

Two Sigma Advisers’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,900
Closed -$270K – 2478
2024
Q4 		$270K Buy
+10,900
New +$309K ﹤0.01% 2022
2024
Q1 		– Sell
-19,400
Closed -$817K – 2536
2023
Q4 		$817K Sell
19,400
-580,900
-97% -$21.4M ﹤0.01% 1725
2023
Q3 		$23M Sell
600,300
-337,600
-36% -$7.63M 0.06% 279
2023
Q2 		$17.8M Buy
937,900
+97,800
+12% +$1.82M 0.05% 333
2023
Q1 		$13M Buy
840,100
+459,200
+121% +$7.97M 0.03% 456
2022
Q4 		$6.76M Buy
380,900
+39,600
+12% +$499K 0.02% 653
2022
Q3 		$1.9M Sell
341,300
-199,100
-37% -$973K 0.01% 1194
2022
Q2 		$2.11M Sell
540,400
-170,600
-24% -$737K 0.01% 1186
2022
Q1 		$3.92M Sell
711,000
-21,300
-3% -$133K 0.01% 917
2021
Q4 		$6.24M Sell
732,300
-276,200
-27% -$2.28M 0.02% 679
2021
Q3 		$8.76M Buy
1,008,500
+184,500
+22% +$1.66M 0.02% 564
2021
Q2 		$8.71M Buy
824,000
+243,500
+42% +$3.4M 0.02% 624
2021
Q1 		$9.31M Buy
580,500
+576,100
+13,093% +$15.2M 0.03% 599
2020
Q4 		$203K Buy
+4,400
New +$203K ﹤0.01% 2168

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Two Sigma Advisers's IMVT Position: Q1 2025 in Review

Two Sigma Advisers sold out of Immunovant (IMVT) in Q1 2025, closing a stake of 10,900 shares — an estimated $270K sold.

Two Sigma Advisers first reported a position in IMVT in Q4 2020 and held it in 14 quarters. The position peaked at $23M in Q3 2023. 193 funds tracked by Wall St. Rank hold IMVT as of Q1 2025.

  • Two Sigma Advisers reported no remaining Immunovant position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 10,900 Immunovant shares in Q1 2025, an estimated $270K.
  • Two Sigma Advisers first reported a position in Immunovant in Q4 2020 and held it in 14 quarters.
  • Two Sigma Advisers's Immunovant position peaked at $23M in Q3 2023.
  • 193 funds tracked by Wall St. Rank held Immunovant as of Q1 2025.

Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.